NHS Lothian nurse becomes first nurse in Scotland to be awarded prestigious Fellowship
The Fellowship, hosted by the School of Health and Wellbeing at the University of Glasgow, has typically been awarded to doctors, but NHS Lothian nurse and clinical academic Kath Williamson was one of four recipients chosen in the 2024 round.
An NHS Lothian nurse has become the first nurse in Scotland to have been awarded a prestigious three-year Chief Scientist Office Early Postdoctoral Research Fellowship.
The Fellowship, hosted by the School of Health and Wellbeing at the University of Glasgow, has typically been awarded to doctors, but NHS Lothian nurse and clinical academic Kath Williamson was one of four recipients chosen in the 2024 round, starting her Fellowship in February 2025.
Prof Juliet MacArthur, Chief Nurse Research and Development for NHS Lothian, said: 'On behalf of my colleagues across NHS Lothian, I want to express how proud we are of Kath's remarkable achievement.
"Securing a Chief Scientist Office Early Postdoctoral Fellowship is a significant milestone in any clinical academic's career, but to be the first nurse in Scotland to do so is truly ground-breaking.
'Kath's success is a testament to her dedication, expertise, and the value of supporting nurses to pursue research careers. The University of Glasgow's School of Health & Wellbeing provides an excellent environment for her work, with its strong focus on tackling health inequalities and improving care for underserved populations.
"We look forward to seeing the impact of her research and clinical innovation in bariatric care, and the inspiration it will provide to other nurses across Scotland.'
Kath's Fellowship programme of work includes the HOPE (Housebound Obesity Pathways and Engagement) study, looking at how housebound people with obesity access weight management interventions.
The wider aim being grant applications for a trial of weight management for housebound people with obesity, with outcomes including improved function, quality of life, mental health and reduced service utilisation.
Alongside research, the Fellowship enables Kath to develop new clinical practices in a first of its kind role as a Clinical Nurse Specialist for bariatric care in the community, one day per week. This unique role, hosted by Community Nursing in Midlothian HSCP, aims to support more effective cross-sector care, in a clinical area where the evidence base is poor but care needs are rising.
Kath, has over 25 years of experience with NHS Lothian in a variety of different roles, including District Nurse, bank nurse, NRS Fellow and most recently, Manual Handling Advisor.
Since 2016, Kath has been supported in developing her research career through the Nursing Midwifery and Allied Health Professional (NMAHP) Research Capacity Building Programme, led by Prof Juliet MacArthur and Andy Peters.
She added: 'I hope that being the first nurse to be awarded a CSO Early Post-doctoral Fellowship will bring other opportunities to role model and promote the potential for nurses to be successful in pursuing clinical academic careers.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
2 days ago
- Glasgow Times
Glasgow University study sheds light on Alzheimer's risk
The research, led by the University of Glasgow, published in the journal npj Dementia, found that while better memory, reasoning, and reaction times were linked to a lower risk of Alzheimer's disease up to 15 years later, this protective effect was significantly reduced in people with a higher genetic risk. Researchers focused on the APOE e4 genotype, which is present in roughly one in four people and is the strongest known genetic predictor of late-onset Alzheimer's. Read more: Glasgow drugs trial to use genetics to 'personalise' treatments A single copy of the APOE e4 gene increases Alzheimer's risk threefold, while two copies raise the risk by twelvefold. Dr Donald Lyall, senior lecturer in population brain health at the University of Glasgow's School of Health and Wellbeing, said: "Our study adds to the knowledge gap that exists on the relationship between genetic factors, cognitive health generally, and subsequent risk of dementia in later life. "Our findings suggest that genetics plays a more significant role than previously thought and may influence the risk or protection conferred by other factors like premorbid cognitive health." In the study, people with above-average reasoning ability were found to have a 36% lower risk of developing Alzheimer's within 15 years. However, for those who also carried the APOE e4 gene, the risk reduction dropped to just 21%. More strikingly, individuals with high reasoning skills but who carried the APOE e4 genotype were more likely to develop Alzheimer's than those with below-average reasoning but no genetic risk factor. The researchers analysed data from over 252,000 UK Biobank participants aged 55 and older, with the average age at the start of the study being just over 62. To ensure long-term accuracy, individuals diagnosed with Alzheimer's within two years of testing were excluded. Researchers excluded individuals diagnosed with Alzheimer's within two years of cognitive testing. The study reinforces the challenges in identifying effective therapies for Alzheimer's, particularly given the influence of genetic factors. Read more: Public urged to shape health board's anti-racism strategy - how you can help Dr Lyall said: "Our study has important implications regarding dementia; namely that genetics clearly plays a significant role in influencing someone's overall risk of Alzheimer's disease as they age." The findings underscore the complex interplay between cognitive health and genetics and the challenges in developing therapies that can effectively prevent or treat Alzheimer's. While cognitive resilience still matters, the research highlights the urgent need to understand genetic risk factors in the fight against one of the world's most devastating neurodegenerative conditions.
Edinburgh Live
3 days ago
- Edinburgh Live
Edinburgh nurse recognised for 'outstanding contributions' in King's Birthday Honours
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info A NHS Lothian nurse has been recognised for her outstanding contributions to epilepsy care in the King's Birthday Honours. Yvonne Leavy, 55, was overwhelmed when she realised that she would be included in the 2025 King's Birthday Honours list for the tireless work she has done over the course of her 37-year career. She said: "It was all so exciting and a bit overwhelming. I didn't even tell my family at first as I was unsure it would actually happen.' The mother-of-three started her career at the age of 18, qualifying to become a nurse in Dundee. She then moved down south to work in London and Oxford, gaining valuable experience and earning her MSc in Epileptology, before returning to Scotland to work as a Epilepsy Specialist Nurse at the former DCN at the Western General Hospital in 2003. Now she's an an integral part of the small and highly specialised team at NHS Lothian and credits her training at renowned epilepsy centres for jump starting her interest and passion in epilepsy. And she's even went on to collaborate with Edinburgh Napier University to develop an online training course for professionals working in epilepsy and contributed to the nursing chapter of The International League of Epilepsy, which supports nurses providing epilepsy care globally. Sign up for Edinburgh Live newsletters for more headlines straight to your inbox She continued: "This award acknowledges the importance of nursing and epilepsy specialist nursing in particular. People with epilepsy face significant challenges and yet they also show incredible dignity and resilience. It is an honour to be involved in helping them to live their lives to the fullest. "I hope the future brings improved funding for this common condition and I am ready to drive this forward alongside my incredible colleagues here in Edinburgh.' Yvonne is one of just 110 recipients in Scotland to be recognised with this prestigious accolade. She joins a list of 1,214 remarkable individuals to be celebrated with this award. Alison MacDonald, Executive Nurse Director, NHS Lothian, added: 'I am absolutely delighted to see Yvonne Leavy recognised in the King's Birthday Honours. 'This is a well-deserved acknowledgement of her outstanding contributions to epilepsy care. 'Yvonne's dedication, expertise and compassion have made a real and lasting difference to the lives of so many patients and families. We are incredibly proud to have her as part of the NHS Lothian team.
Daily Mail
3 days ago
- Daily Mail
Eric Dane issues major ALS battle update as he promises fans 'I'm fighting as much as I can'
Eric Dane has given a huge update on his battle with incurable degenerative neurological disorder, amyotrophic lateral sclerosis (ALS). 'I'm fighting as much as I can,' the 52-year-old Grey's Anatomy alum told Good Morning America 's Diane Sawyer on Tuesday. 'There's so much about it that's out of my control.' Eric is currently taking medication to slow the symptoms and he's also participating in a research study. 'I will fly to Germany and eat the head off a rattlesnake if [doctors] told me that that would help,' Dane stressed. 'I'll assume the risk.' The SAG Award winner was joined by his neurologist Dr. Merit Cudkowicz, who admitted: 'It's a hard diagnosis to hear, but I want [patients] to hear that there's hope. I never want anyone to hear that there's nothing to do because there's a lot to do.' 'That's what I got from Merit when I met her. There was a sense of hope I didn't get from other doctors that I met with,' Eric noted, adding prior doctors were just 'there to monitor my decline and that's not very helpful.' There are currently 5K people diagnosed with ALS annually, according to the CDC. 'But those numbers are going up moderately fast,' the Chief of Neurology at Mass General warned. 'It's really predicted by, like, 2040 [that] the numbers of people with ALS in the world will be increased by about 40%.' Dr. Cudkowicz listed off some of the ALS risk factors including plastics, bacteria in lakes, head trauma in sports, pesticides, military service, and 'there's many more we don't know about.' 'There's people all over the world working on this,' the Harvard Medical School professor encouraged. 'Between artificial intelligence and other imaging technology - to really be able to to subtype people - that's what gets me excited. That's all coming in the next, I think, one to two years, if not faster.' Back in 2014, the viral ice-bucket challenge raised $200M for ALS research 'in the US alone and it was spent quickly.' 'I'm very hopeful, yeah, I don't think this is the end of my story. I'm pretty resilient,' Eric beamed. 'I just don't feel, like in my heart, [that] this is the end of me.' Dane first experienced weakness in his right hand one year ago, but he 'thought maybe I'd been texting too much or my hand was fatigued' until a hand specialist eventually referred him to a neurologist. 'I will fly to Germany and eat the head off a rattlesnake if [doctors] told me that that would help,' Dane stressed. 'I'll assume the risk' 'That's what I got from Merit when I met her. There was a sense of hope I didn't get from other doctors that I met with,' Eric noted, adding prior doctors were just 'there to monitor my decline and that's not very helpful' There are currently 5K people diagnosed with ALS annually, 'but those numbers are going up moderately fast,' the Chief of Neurology at Mass General warned 'I have one functioning arm. My left side is functioning. My right side, [which is my dominant side], has completely stopped working,' the San Francisco-born silver fox revealed Monday. '[My left arm] is going. I feel like maybe a couple, a few more months and I won't have my left hand either. Sobering. I'm worried about my legs.' Luckily, Eric has the love and support of his wife Rebecca Gayheart, who dismissed her divorce petition in March following seven years of estrangement, as well as their 15-year-old daughter Billie and 13-year-old daughter Georgia. 'I talk to her every day,' Dane emotionally said of the 53-year-old Jawbreaker alum. 'We have managed to become better friends and better parents. And she is probably my biggest champion and my most stalwart supporter. And I lean on her.' On average, ALS patients live two to five years following their first symptoms, but FDA-approved medications and physical/speech therapies might slow down the progression of the disorder. Audiences can next catch the Bad Boys: Ride or Die action star as Special Agent Nathan Blythe in Derek Haas' new 13-episode crime drama Countdown, which premieres June 25 on Amazon Prime Video. On April 14, Eric began reprising his role as the closeted real estate agent Cal Jacobs in the third season of HBO hit show Euphoria produced by and starring Zendaya as Ruby 'Rue' Bennett. Sam Levinson's drug-fueled drama will welcome newcomers Sharon Stone, Rosalía, Marshawn Lynch, and Kadeem Hardison in season three. But Dane got his big break portraying plastic surgeon Mark 'McSteamy' Sloan from 2006–2012 on the ABC medical drama Grey's Anatomy.
